As a biocluster accredited since 2005, Lyonbiopole Auvergne-Rhône-Alpes, is the catalyst for healthcare innovation in the region. It connects and supports industry leaders, SMEs, academics, and hospital stakeholders in developing innovative solutions in biotech, medtech, and digital healthtech. By fostering synergies and driving business growth, it strengthens the region’s attractiveness and contributes to shaping the future of the healthcare industry in Auvergne-Rhône-Alpes, while advancing medical progress for the benefit of patients worldwide. Among its 251 members, the cluster’s board includes 6 permanent members (Boehringer Ingelheim, bioMérieux, CEA, Fondation Mérieux, Hospices Civils de Lyon, and Sanofi), 21 major corporations, subsidiaries, and mid-sized companies, 196 innovative SMEs, 13 research and training centers, 5 healthcare and research institutions, 1 local authority, and 6 associate members. As a member of the national health cluster alliance Enosis Santé, Lyonbiopôle provides access to France’s most dynamic healthcare ecosystems. Learn more at: www.lyonbiopole.com